BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Chiesi Farmaceutici SpA 

Via Palermo 26/ A

Parma    43100  Italy
Phone: 39-0521-279-230 Fax: 39-0521-774468


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
uniQure And Chiesi Farmaceutici SpA Announce Six Year Follow-up Data from Glybera® Treated Patients 3/17/2014 8:58:30 AM
Chiesi Farmaceutici SpA Completes Acquisition Of Cornerstone Therapeutics Inc. 2/4/2014 9:58:06 AM
Selvita Extends Long-Term Chemistry Collaboration With Chiesi Farmaceutici SpA 1/10/2014 10:12:55 AM
Chiesi Farmaceutici SpA to Buy Rest of Cornerstone Therapeutics Inc. for $255 Million 9/16/2013 6:52:01 AM
CereSpir Incorporated Announces Letter of Intent With Chiesi Farmaceutici SpA to License Worldwide Development and Commercialization Rights for CHF 5074 to CereSpir 7/26/2013 10:01:33 AM
CereSpir Incorporated is Pleased With Positive Interim Phase 2 Results for CHF 5074 in Patients With Mild Cognitive Impairment, Presented by Chiesi Farmaceutici SpA at the AAIC 2013 Meeting in Boston 7/26/2013 9:53:35 AM
uniQure, Chiesi Farmaceutici SpA Strike $58 Million Deal for Hemophilia B Development 7/9/2013 7:30:38 AM
Eddingpharm (Cayman) Inc. and Chiesi Farmaceutici SpA Form Asthma Drug JV 4/16/2013 9:08:36 AM
Cornerstone Therapeutics Inc. Acquires Exclusive U.S. Rights to Chiesi Farmaceutici SpA's BETHKIS® (Tobramycin Inhalation Solution) 11/8/2012 9:21:39 AM
Veloxis Pharmaceuticals A/S (VELO), Chiesi Farmaceutici SpA Ink $47.5 Million Pact 10/5/2012 7:02:49 AM
1234